Shareable Research Card

MDNC - Medinotec Inc. Increase (Decrease) in Accounts Receivable

This metric view shows MDNC - Medinotec Inc. increase (decrease) in accounts receivable history from SEC company facts.

Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.

Context
Latest reported period: 2025
Latest reported value
$259,965

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.

Return Loop

Why revisit this metric view

This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.

Latest source-backed update
Latest period end 28 Feb 2026
Why come back
Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
  • Current latest reported period: 2025.
  • Latest reported value on this page: $259,965.
  • Save this filer if you want to compare the next reported value with this history.

Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.

Latest update

Latest update for Increase (Decrease) in Accounts Receivable

New fact period available

Latest reported increase (decrease) in accounts receivable: $259,965. Open the source-backed page to compare this metric with the newest filing-backed context.

Update date

28 Feb 2026

Page type

Metric history

Latest period

2025

SEC-backed company facts were refreshed from filings filed on 28 May 2026.

Benchmark Context

How Increase (Decrease) in Accounts Receivable compares with peers

Medinotec Inc. is outside the visible top 120 companies for increase (decrease) in accounts receivable in the current sample.

Compared with

Compared with 120 companies reporting increase (decrease) in accounts receivable in USD. This keeps the comparison on the same metric and unit family.

Why this is notable

This is about 0x the current sample midpoint. Increase (Decrease) in Accounts Receivable does not yet have enough prior-period data for a historical comparison on this page.

  • Visible rows currently span reported period ends from 31 Mar 2021 to 02 May 2026.
  • Nearby companies in this sample: Dell Technologies Inc. and ARROW ELECTRONICS, INC..
  • Peer rows use the latest valid value per company for this exact metric and compatible units.

Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Financial Metric Page

Medinotec Inc.: Increase (Decrease) in Accounts Receivable

Latest period: 2025. Period end: 28 Feb 2026. Units: USD. Frequency: annual and quarterly.

The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.

What this metric tells you

  • Shows reported increase (decrease) in accounts receivable over 30 Sep 2021 - 28 Feb 2026.
  • Use consecutive periods in the table to assess trend direction when YoY change is unavailable.
  • Built from 10 SEC fact rows for this metric and issuer.

How to read this chart

  • Start with the latest point, then compare it with the prior periods to see direction.
  • Use annual sequence to compare like-for-like periods.
  • Use YoY change bars to separate growth from contraction across matching periods.

Compare This Metric Across Companies

Compare latest available Increase (Decrease) in Accounts Receivable levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.

Metric Details

Metric identity Names, identifiers, and filing context for this profile. 1 identity field
Taxonomy
us-gaap
Metric coverage 3 source fields
Units tracked
USD
History range
30 Sep 2021 - 28 Feb 2026
Freshness: From parsed SEC XBRL facts on this page
Facts on this page
10
Source: SEC company facts API
How to read it 1 detail
Metric definition
The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
Source evidence Original filing metadata and source links for verification. 1 source field
SEC metric endpoint
Open SEC company concept

Chart Context

Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.

Increase (Decrease) in Accounts Receivable, Annual (USD)
Increase (Decrease) in Accounts Receivable, YoY Annual Change (%)
Increase (Decrease) in Accounts Receivable, Quarterly (USD)
Increase (Decrease) in Accounts Receivable, YoY Quarterly Change (%)

Medinotec Inc. Annual Increase (Decrease) in Accounts Receivable (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $259,965 +$2,299,211 01 Mar 2025 28 Feb 2026 10-K 28 May 2026 2026 FY
2024 $2,039,246 -$1,407,998 -223% 01 Mar 2024 28 Feb 2025 10-K 28 May 2026 2026 FY
2023 $631,248 -$610,229 -2903% 01 Mar 2023 29 Feb 2024 10-K 29 May 2025 2025 FY
2022 $21,019 01 Mar 2022 28 Feb 2023 10-K 05 Jul 2024 2024 FY

Medinotec Inc. Quarterly Increase (Decrease) in Accounts Receivable (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $1,589,455 -$1,897,886 -615% 01 Mar 2025 31 May 2025 10-Q 16 Jul 2025 2026 Q1
Q2 2024 $308,431 +$548,057 01 Mar 2024 31 May 2024 10-Q 16 Jul 2025 2026 Q1
Q2 2023 $239,626 -$248,687 -2745% 01 Mar 2023 31 May 2023 10-Q 12 Jul 2024 2025 Q1
Q3 2022 $258,411 +$228,966 +778% 01 Jul 2022 30 Sep 2022 10-Q 17 Jan 2023 2023 Q3
Q2 2022 $9,061 01 Mar 2022 31 May 2022 10-Q 14 Jul 2023 2024 Q1
Q3 2021 $29,445 01 Jul 2021 30 Sep 2021 10-Q 17 Jan 2023 2023 Q3
* marks a reported value that did not pass the local value check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .